Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Profit After Tax: 2022-2024

Historic Profit After Tax for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to -$98.3 million.

  • Lexeo Therapeutics' Profit After Tax rose 2.79% to -$14.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$66.4 million, marking a year-over-year change of. This contributed to the annual value of -$98.3 million for FY2024, which is 48.09% down from last year.
  • Per Lexeo Therapeutics' latest filing, its Profit After Tax stood at -$98.3 million for FY2024, which was down 48.09% from -$66.4 million recorded in FY2023.
  • Over the past 5 years, Lexeo Therapeutics' Profit After Tax peaked at -$59.3 million during FY2022, and registered a low of -$98.3 million during FY2024.
  • Moreover, its 3-year median value for Profit After Tax was -$66.4 million (2023), whereas its average is -$74.7 million.
  • Data for Lexeo Therapeutics' Profit After Tax shows a maximum YoY crashed of 48.09% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Lexeo Therapeutics' Profit After Tax stood at -$59.3 million in 2022, then declined by 11.97% to -$66.4 million in 2023, then tumbled by 48.09% to -$98.3 million in 2024.